Cargando…

COVID-related disruption in mammographic screening: a year later

Detalles Bibliográficos
Autores principales:	Toss, A., Callegari, V., Cortesi, G., Civallero, M., Armocida, C., Piacentini, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278125/ https://www.ncbi.nlm.nih.gov/pubmed/35841805 http://dx.doi.org/10.1016/j.esmoop.2022.100539

Ejemplares similares

Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era
por: Toss, A., et al.
Publicado: (2021)

Response to: COVID-related upsurge in diagnoses of advanced breast cancer—is a disruption in mammography screening the one to be blamed?
por: Toss, A.
Publicado: (2021)

Cherry-picking of evidence fails to accurately show extent of overdiagnosis: Mammographic screening harms understated
por: Woolley, Emma
Publicado: (2013)

Mammographic screening and mammographic patterns
por: Day, Nick, et al.
Publicado: (2000)

Letter in response to “Cherry-picking of evidence fails to accurately show extent of overdiagnosis: Mammographic screening harms understated”
por: Lee, Warwick, et al.
Publicado: (2013)

Mammographic density and risk of breast cancer recurrence and mortality
por: Liu, Lipeng, et al.
Publicado: (2022)

The first two years of digital mammographic screening in New Zealand
por: Walker, J, et al.
Publicado: (2008)

RE: Chemopreventive Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials
por: Hopper, John L, et al.
Publicado: (2021)

Molecular Biomarkers for Prediction of Targeted Therapy Response in Metastatic Breast Cancer: Trick or Treat?
por: Toss, Angela, et al.
Publicado: (2017)

Are you treating ypN0 patient with adjuvant abemaciclib?
por: Toss, A., et al.
Publicado: (2023)

Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis
por: Li, Chunyu, et al.
Publicado: (2023)

Updated results of the Gothenburg Trial of Mammographic Screening
por: Bjurstam, Nils G., et al.
Publicado: (2016)

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy
por: Toss, Angela, et al.
Publicado: (2022)

Projecting COVID-19 disruption to elective surgery
Publicado: (2022)

The relative effect of mammographic screening on breast cancer mortality by socioeconomic status
por: Ripping, Theodora M., et al.
Publicado: (2016)

Germline Mutations in Other Homologous Recombination Repair-Related Genes Than BRCA1/2: Predictive or Prognostic Factors?
por: Cortesi, Laura, et al.
Publicado: (2021)

Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme.
por: van Dijck, J., et al.
Publicado: (1996)

Mammographic screening for breast cancer: A review
por: Lee, Warwick, et al.
Publicado: (2013)

Mammographic density. Measurement of mammographic density
por: Yaffe, Martin J
Publicado: (2008)

Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits
por: Berrington de González, A, et al.
Publicado: (2005)

Nephrology Trainee Education Needs Assessment: Five Years and a Pandemic Later
por: Ko, Benjamin S., et al.
Publicado: (2022)

The need of an updated culture of “occupational” atopic hand dermatitis in children at the time of COVID-19
por: Pecoraro, Luca, et al.
Publicado: (2022)

Effectiveness of Mammographic Screening for Breast Cancer in Women Aged over 50 Years in Japan
por: Morimoto, Tadaoki, et al.
Publicado: (1997)

Mammographic density
por: Boyd, Norman F, et al.
Publicado: (2009)

Mammographic screening with a breast cancer prevention programme
por: Boyle, P
Publicado: (2004)

Thoughts of an Old Surgeon on the New Mammographic Screening Guidelines
por: Iwasiuk, Gosta W
Publicado: (2019)

Mammographic features associated with interval breast cancers in screening programs
por: Boyd, Norman F, et al.
Publicado: (2014)

Breast density as a determinant of interval cancer at mammographic screening
por: Ciatto, S, et al.
Publicado: (2004)

Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years
por: Moss, S, et al.
Publicado: (2005)

Advanced breast cancer incidence following population-based mammographic screening
por: Autier, P., et al.
Publicado: (2011)

Mammographic screening detects low-risk tumor biology breast cancers
por: Drukker, C. A., et al.
Publicado: (2014)

The implications of increased mammographic breast density for breast screening in Jordan
por: Al‐Mousa, Dana S., et al.
Publicado: (2020)

Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β(2)-Agonist–Only Treatment
por: Baraldi, Eugenio, et al.
Publicado: (2022)

Cerebellar rTMS disrupts predictive language processing
por: Lesage, Elise, et al.
Publicado: (2012)

Personalized Systemic Therapies in Hereditary Cancer Syndromes
por: Mastrodomenico, Luciana, et al.
Publicado: (2023)

Histopathologic indicators of breast cancer biology: insights from population mammographic screening
por: Webster, L R, et al.
Publicado: (2005)

Radiological review of interval cancers in an Australian mammographic screening programme
por: Cawson, J, et al.
Publicado: (2000)

Can mammographic features predict invasive carcinoma at screening assessment?
por: Forester, ND, et al.
Publicado: (2011)

Improved fracture detection using the mammographic film-screen combination
por: Faridah, Y, et al.
Publicado: (2005)

Supplementary Screening Sonography in Mammographically Dense Breast: Pros and Cons
por: Youk, Ji Hyun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kcht4ckq6uo8iliet2tsa9r8pc